fluoxetine has been researched along with Muscular Dystrophy, Duchenne in 2 studies
Fluoxetine: The first highly specific serotonin uptake inhibitor. It is used as an antidepressant and often has a more acceptable side-effects profile than traditional antidepressants.
fluoxetine : A racemate comprising equimolar amounts of (R)- and (S)-fluoxetine. A selective serotonin reuptake inhibitor (SSRI), it is used (generally as the hydrochloride salt) for the treatment of depression (and the depressive phase of bipolar disorder), bullimia nervosa, and obsessive-compulsive disorder.
N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine : An aromatic ether consisting of 4-trifluoromethylphenol in which the hydrogen of the phenolic hydroxy group is replaced by a 3-(methylamino)-1-phenylpropyl group.
Muscular Dystrophy, Duchenne: An X-linked recessive muscle disease caused by an inability to synthesize DYSTROPHIN, which is involved with maintaining the integrity of the sarcolemma. Muscle fibers undergo a process that features degeneration and regeneration. Clinical manifestations include proximal weakness in the first few years of life, pseudohypertrophy, cardiomyopathy (see MYOCARDIAL DISEASES), and an increased incidence of impaired mentation. Becker muscular dystrophy is a closely related condition featuring a later onset of disease (usually adolescence) and a slowly progressive course. (Adams et al., Principles of Neurology, 6th ed, p1415)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Fluoxetine 5 mg/day was started and gradually increased to 20 mg/day." | 1.43 | Diagnosis and treatment of obsessive compulsive behavior in a boy with Duchenne muscular dystrophy and autism spectrum disorder: A case report. ( Collin, P; Hendriksen, JG; Klinkenberg, S; Niks, EH; Vles, JS; Wong, B, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Waugh, TA | 1 |
| Horstick, E | 1 |
| Hur, J | 1 |
| Jackson, SW | 1 |
| Davidson, AE | 1 |
| Li, X | 1 |
| Dowling, JJ | 1 |
| Hendriksen, JG | 1 |
| Klinkenberg, S | 1 |
| Collin, P | 1 |
| Wong, B | 1 |
| Niks, EH | 1 |
| Vles, JS | 1 |
2 other studies available for fluoxetine and Muscular Dystrophy, Duchenne
| Article | Year |
|---|---|
Fluoxetine prevents dystrophic changes in a zebrafish model of Duchenne muscular dystrophy.
Topics: Animals; Base Sequence; Birefringence; Calcium; Disease Models, Animal; Drug Evaluation, Preclinical | 2014 |
Diagnosis and treatment of obsessive compulsive behavior in a boy with Duchenne muscular dystrophy and autism spectrum disorder: A case report.
Topics: Autism Spectrum Disorder; Child; Comorbidity; Fluoxetine; Humans; Male; Muscular Dystrophy, Duchenne | 2016 |